Lumacaftor (VX-809)

lumacaftor · Vertex Pharmaceuticals Incorporated

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Lumacaftor (VX-809), covering 2012-01-18 to 2014-08-11. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1, QT/QTC Interval Study in Healthy Subjects [Phase 1]